What Is IDXX Fair Value?
Idexx Laboratories (IDXX) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Idexx Laboratories (IDXX) has a composite fair value estimate of $173.39 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $529.01, suggesting the stock is overvalued by 67.2%.
Data as of October 14, 2026 (today)
Composite Fair Value
Overvalued3 of 4 models$173.39
vs. current price of $529.01(-67.2%)
How Is IDXX Fair Value Calculated?
Four independent models estimate what IDXX is worth. Each uses different inputs and assumptions. The composite blends them by weight.
IDXX Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$190.03
-64.1%Overvalued
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
IDXX Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$82.59
-84.4%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$193.94
-63.3%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $529.01 is 64.1% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.03B | $911.8M |
| Year 2 | $1.16B | $914.2M |
| Year 3 | $1.31B | $916.6M |
| Year 4 | $1.49B | $919.0M |
| Year 5 | $1.68B | $921.4M |
| Year 6 | $1.90B | $923.9M |
| Year 7 | $2.15B | $926.3M |
| Year 8 | $2.43B | $928.8M |
| Year 9 | $2.75B | $931.2M |
| Year 10 | $3.11B | $933.7M |
| Terminal Value | $30.99B | $9.31B |
What Are IDXX's Key Financial Metrics?
Earnings & Growth
Current Price
$529.01
EPS (TTM)
$14.07
Forward P/E
31.6
Profit Margin
25.0%
Cash & Balance Sheet
Free Cash Flow
909.4M
EBITDA
1.6B
Book Value
$20.45
Total Debt
1.1B
What Do Analysts Say About IDXX?
Low
$470.00
Average
$701.33
High
$805.00
Upside
+32.6%
IDXX Fair Value FAQ
What is the fair value of IDXX?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), IDXX's estimated fair value is $173.39. The stock is currently trading at $529.01, which makes it overvalued by our analysis.
How is IDXX's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is IDXX overvalued or undervalued?
Based on our analysis, IDXX is overvalued. The current price of $529.01 is 67.2% above our estimated fair value of $173.39.
What do Wall Street analysts say about IDXX?
12 analysts cover Idexx Laboratories with a consensus rating of "Buy." The average price target is $701.33, ranging from $470.00 to $805.00. This implies 32.6% upside from the current price.